Skip to Main content Skip to Navigation
Journal articles

Ketamine‐Magnesium for Refractory Chronic Cluster Headache: A Case Series

Abstract : Objectives.-To evaluate the safety and efficacy of ketamine-magnesium combination to reduce attacks in a series of patients with refractory chronic cluster headache (rCCH). Background.-Refractory chronic cluster headache (CCH) is a rare but highly debilitating condition that needs new treatment options. A previous publication reported that a single infusion of ketamine-magnesium combination was effective in 2 patients with rCCH. Methods.-The treatment was proposed to consecutive patients with rCCH seen in 2 French hospitals between November 2015 and February 2020 and who were resistant to at least 3 preventive treatments. They received a single ketamine infusion (0.5 mg/kg over 2 hours) combined with magnesium sulfate (3000 mg). The main outcome was a comparison of the number of daily attacks 2 weeks prior to the ketamine-magnesium infusion and 1 week after (on days 7 and 8). The second outcome was the percentage of responders (patients with ≥50% reduction in the frequency of daily attacks). Safety was assessed by the recording of adverse events during infusion. Descriptive statistics are presented as mean ± standard deviation. Results.-Seventeen patients (14 men), with an age of 35.2 ± 8.1 years, were included. They presented with CCH for 6.6 ± 4.3 years. The number of daily attacks decreased from 4.3 ± 2.4 before treatment to 1.3 ± 1.0 after treatment (difference: −3.1 (95% CI: −4.5 to −1.6), P < .001). Seventy six percent (13/17) were responders. Transient and mild sedation was reported by 7/17 patients (41.2%). Conclusions.-The ketamine-magnesium combination seems an effective and well-tolerated therapy for rCCH. Placebocontrolled studies should be conducted to further confirm these findings.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03112418
Contributor : Radhouane Dallel <>
Submitted on : Saturday, January 16, 2021 - 6:05:58 PM
Last modification on : Tuesday, February 23, 2021 - 1:32:01 PM
Long-term archiving on: : Saturday, April 17, 2021 - 6:20:55 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Xavier Moisset, Pierric Giraud, Estelle Meunier, Sakahlé Condé, Maud Périé, et al.. Ketamine‐Magnesium for Refractory Chronic Cluster Headache: A Case Series. Headache: The Journal of Head and Face Pain, American Headache Society, 2020, 60 (10), pp.2537 - 2543. ⟨10.1111/head.14005⟩. ⟨inserm-03112418⟩

Share

Metrics

Record views

124